Clinical Trial Detail

NCT ID NCT01813214
Title The Effects of Vemurafenib on Immunity in Patients With Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Georgetown University
Indications

melanoma

Therapies

Vemurafenib

Age Groups: adult

Additional content available in CKB BOOST